Comment on Yli-Vakkuri and Hawthorne, Narrow Content by Byrne, A

Get full text

Arthur's refusal to eat: ritual and control in the romance feast by Byrne, A

FAMILY, LOCALITY, AND NATIONALITY: VERNACULAR ADAPTATIONS OF THE EXPUGNATIO HIBERNICA IN LATE MEDIEVAL IRELAND by Byrne, A

Musteloid diseases: implications for conservation and species management by Newman, C, Byrne, A

IRF5 is a specific marker of inflammatory macrophages in vivo. by Weiss, M, Blazek, K, Byrne, A, Byrne, A, Perocheau, D, Udalova, I

Effects of mood on delay of gratification in primary school children by Turnbull, S, Byrne, A, Carroll, D

Mean-field approximations with adaptive coupling for networks with spike-timing-dependent plasticity by Duchet, B, Bick, C, Byrne, Á

Push and pull factors driving movement in a social mammal: context dependent behavioural plasticity at the landscape scale by Byrne, A, O'Keeffe, J, Buesching, C, Newman, C

Mean-field approximation for networks with synchrony-driven adaptive coupling by Fennelly, N, Neff, A, Lambiotte, R, Keane, A, Byrne, A

A critical role for IRF5 in regulating allergic airway inflammation by Byrne, A, Weiss, M, Mathie, S, Walker, S, Eames, H, Saliba, D, Lloyd, C, Udalova, I

The S. Typhi effector StoD is an E3/E4 ubiquitin ligase which binds K48- and K63-linked diubiquitin by McDowell, M, Byrne, A, Mylona, E, Johnson, R, Sagfors, A, Crepin, V, Lea, S, Frankel, G

Language phenotypes in children with sex chromosome trisomies by Bishop, D, Brookman-Byrne, A, Gratton, N, Gray, E, Holt, G, Morgan, L, Morris, S, Paine, E, Thornton, H, Thompson, P

Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach. by Vader, P, van der Meel, R, Symons, M, Fens, M, Pieters, E, Wilschut, K, Storm, G, Jarzabek, M, Gallagher, WM, Schiffelers, R, Byrne, A

IRF5:RelA interaction targets inflammatory genes in macrophages. by Saliba, D, Heger, A, Eames, H, Oikonomopoulos, S, Teixeira, A, Blazek, K, Androulidaki, A, Wong, D, Goh, F, Weiss, M, Byrne, A, Pasparakis, M, Ragoussis, J, Udalova, I

Lentivirus gene therapy for autoimmune pulmonary alveolar proteinosis by Palau, H, Meng, C, Bhargava, A, Pilou, A, Atsumi, N, Byrne, A, Pringle, I, Ashworth, R, Chan, M, Gill, D, Hyde, S, Morgan, C, Alton, E, Griesenbach, U

Lentivirus GM-CSF gene therapy ameliorates autoimmune pulmonary alveolar proteinosis by Lund-Palau, H, Meng, C, Pilou, A, Atsumi, N, Bhargava, A, Chan, M, Byrne, A, Pringle, I, Ashworth, R, Gill, D, Hyde, S, Morgan, C, Alton, E, Griesenbach, U

Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment/ by 495889 Byrne, A. T., O'Connor, AE, Hall, M, Murtagh, J, O'Neill, K, Curran, K. M., Mongrain, K, Rousseau, JA, Lecomte, R, McGee, S, Callanan, J. J., O'Shea, D. F., Gallagher, WM

Support needs and barriers to accessing support: baseline results of a mixed-methods national survey of people bereaved during the COVID-19 pandemic by Harrop, E, Goss, S, Farnell, D, Longo, M, Byrne, A, Barawi, K, Torrens-Burton, A, Nelson, A, Seddon, K, Machin, L, Sutton, E, Roulston, A, Finucane, A, Penny, A, Smith, K, Sivell, S, Selman, L

An enhanced CRISPR repressor for targeted mammalian gene regulation by Yeo, NC, Chavez, A, Lance-Byrne, A, Chan, Y, Menn, D, Milanova, D, Kuo, C-C, Guo, X, Sharma, S, Tung, A, Cecchi, RJ, Tuttle, M, Pradhan, S, Lim, ET, Davidsohn, N, Ebrahimkhani, MR, Collins, JJ, Lewis, NE, Kiani, S, Church, GM

CARer-ADministration of as-needed subcutaneous medication for breakthrough symptoms in homebased dying patients (CARiAD): study protocol for a UK-based open randomised pilot trial by Poolman, M, Roberts, J, Byrne, A, Perkins, P, Hoare, Z, Nelson, A, Hiscock, J, Hughes, D, Foster, B, O'Connor, J, Reymond, L, Healy, S, Roberts, R, Wee, B, Lewis, P, Johnstone, R, Roberts, S, Holmes, E, Wright, S, Hendry, A, Wilkinson, C